The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial of pomalidomide for children with recurrent, progressive/refractory central nervous system (CNS) tumors: A Pediatric Brain Tumor Consortium (PBTC) study.
 
Jason R. Fangusaro
No Relationships to Disclose
 
Duane Anthony Mitchell
Consulting or Advisory Role - Tocagen
Research Funding - Immunimic Therapeutics, In.
Patents, Royalties, Other Intellectual Property - Annias Immunotherapeutics, Inc.; Celdex Therapeutics
 
Mehmet Kocak
No Relationships to Disclose
 
Arzu Onar-Thomas
Research Funding - AstraZeneca (Inst); Celgene (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Zsila Sousan Sadighi
No Relationships to Disclose
 
Patricia Ann Baxter
No Relationships to Disclose
 
Eugene I. Hwang
No Relationships to Disclose
 
Jianping Huang
No Relationships to Disclose
 
Ira J. Dunkel
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst)
 
Maryam Fouladi
Research Funding - Merck (Inst)
 
Katherine E. Warren
No Relationships to Disclose